Z&T Pharma s.r.o.

Active
IČO 47664479limited liability company (s.r.o.)Founded 2014Bratislava - mestská časť Ružinov

Key figures

14 540 077 €+36,8%
Revenue 2025
+86,6%
Average annual growth 2020–2025
05 m10 m15 m202020212022202320242025

Key figures

2025

Dividends

calculated
2025

No dividends were distributed.

Equity decreased by 170 000 € other than from retained earnings — e.g. a share capital reduction, a payout from other funds or a revaluation. The open data does not show whether this was a payout to shareholders.

History
dividends other decrease in equity
20250 €+170 000 € other
20240 €
20230 €
20220 €
20210 €

Summary: Z&T Pharma s.r.o.

What kind of company is it?

Z&T Pharma s.r.o. (IČO 47664479) is a limited liability company (s.r.o.). The company was incorporated in 2014 and has existed for 12 years. Registered office according to the register: Bratislava - mestská časť Ružinov. Main activity according to the Statistical Office: maloobchod s farmaceutickými výrobkami (SK NACE 4773). Size category by number of employees: 5–9 employees.

Who runs the company and who owns it?

The statutory body has 2 members. According to the register, the company has one shareholder. The registered capital is 5 000 €.

How is the company doing financially?

Revenue for 2025 was 14 540 077 €, up 36,8 % on the previous year (10 628 537 €). From 2020 to 2025, revenue grew by an average of 86,6 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 67 431 € (0,5 % of revenue). The company was profitable in 5 of the 6 reported years. Personnel costs for 2025 were 85 613 €. At the end of 2025 the company had total assets of 3 554 239 € and equity of 502 431 € (equity ratio 14,1 %).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 20. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)3 054 5746 747 5088 626 91110 628 53714 540 077
Profit for the reporting year46 24244 09251 41540 09067 431
Retained earnings of previous periods-41 8394 40348 49599 910140 000
Total assets967 1901 347 0212 078 4192 815 3313 554 239
Total liabilities807 7871 143 5261 823 5092 210 3313 051 808
Total equity159 403203 495254 910605 000502 431
Calculated dividends00000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph

Click a company to see its connections.

100 %directordirector50 %50 %99,96 % · director0,04 %80 % · director20 %Z&T Pharma s.r.o.Z&T Pharma s.r.o.GBGabriel BodorGabriel BodorLBLucia BodorLucia BodorGLIng. Gustáv LacaIng. Gustáv LacaELEma LacováEma LacováGBGabriel BodorGabriel BodorLBBc. Lucia BodorBc. Lucia Bodor
PersonCompanyOwnership (thickness = share)Role in a bodyZoom: Ctrl/⌘ + wheel

The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.

Documents in the Register of Financial Statements12

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same industry (SK NACE 4773)
Z&T Pharma s.r.o. (IČO 47664479) – revenue 14,5M € | icoprofil.sk